Want to see FR:OSE full AI Analyst Report?
OSE Immunotherapeutics SA (OSE) Income Statement
OSE Immunotherapeutics SA Income Statement
Last quarter (Q4 2025), OSE Immunotherapeutics SA's total revenue was $1.30M, an increase of 49.14% from the same quarter last year. In Q4, OSE Immunotherapeutics SA's net income was $-22.59M. See OSE Immunotherapeutics SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.62M | $ 69.88M | $ 2.23M | $ 18.30M | $ 26.31M | |
| $ 2.62M | $ 69.88M | $ 2.23M | $ 18.30M | $ 26.31M | |
| $ 39.19M | $ 41.52M | $ 25.21M | $ 36.78M | $ 42.93M | |
| Depreciation and Amortization | $ 3.25M | $ 3.31M | $ 3.52M | $ 3.54M | $ 2.66M |
| $ -44.81M | $ 41.14M | $ -17.50M | $ -13.11M | $ -13.72M | |
| $ -48.06M | $ 43.73M | $ -22.99M | $ -18.48M | $ -16.63M | |
| $ 6.00M | $ -3.90M | $ -235.00K | $ 454.00K | $ -588.00K | |
| $ -42.05M | $ 39.83M | $ -23.22M | $ -23.45M | $ -21.56M | |
| $ -37.70M | $ 37.45M | $ -23.00M | $ -17.76M | $ -16.85M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.69 | $ 1.72 | $ -1.18 | $ -0.96 | $ -0.93 |
| Diluted EPS | $ -1.69 | $ 1.72 | $ -1.18 | $ -0.96 | $ -0.93 |
| Weighted Average Shares Outstanding | 22.31M | 21.81M | 19.56M | 18.46M | 18.16M |
| Weighted Average Shares Outstanding (Diluted) | 22.31M | 21.81M | 19.56M | 18.46M | 18.16M |
Currency in EUR
